Innovators Vs. Exploiters: Drug Pricing And The Future Of Pharma

Pharmaceutical pricing got thrown onto the front page again last week, causing the expected anaphylactic reactions among politicians, practitioners and parents. The root of this crisis: EpiPen’s 600% price increase over the past eight years. The biannual upticks underlying that number finally caused a blowback as back-to-school buyers were faced with big out-of-pocket expenses this year that their insurers passed on to them.